調查批次:CHT2017-04 | 檢體寄出日期:2017-09-25 | 報告回收截止日期:2017-10-02 | 回收份數:22 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 1 |
2 |
5 |
3.19 |
-0.34 |
-9.6 |
-1.2 |
-0.3 |
-40 |
1.56 |
-0.05 |
-3.1 |
-0.4 |
0.1 |
-13 |
RH07b | RH07 | 4 |
2 |
3 |
3.80 |
0.27 |
7.6 |
1.0 |
0.5 |
32 |
1.38 |
-0.23 |
-14.3 |
-1.8 |
-1.0 |
-59 |
RH14 | RH14 | 4 |
2 |
3 |
3.85 |
0.32 |
9.1 |
1.1 |
0.6 |
38 |
1.57 |
-0.04 |
-2.5 |
-0.3 |
0.2 |
-10 |
RH15 | RH15 | 4 |
2 |
5 |
3.00 |
-0.53 |
-15.0 |
-1.9 |
-0.5 |
-63 |
1.64 |
0.03 |
1.9 |
0.2 |
0.6 |
8 |
CL009 | CL009 | 4 |
2 |
5 |
2.71 |
-0.82 |
-23.2 |
-2.9 |
-0.9 |
-97 |
1.47 |
-0.14 |
-8.7 |
-1.1 |
-0.4 |
-36 |
CL010 | CL010 | 4 |
2 |
5 |
2.71 |
-0.82 |
-23.2 |
-2.9 |
-0.9 |
-97 |
1.39 |
-0.22 |
-13.7 |
-1.7 |
-0.9 |
-57 |
CL012 | CL012 | 7 |
2 |
3 |
4.74 |
1.21 |
34.3 |
4.3 |
1.7 |
143 |
2.15 |
0.54 |
33.5 |
4.2 |
3.7 |
140 |
Median of RIA Group |
3.19 |
1.56 |
||||||||||||||
Range of RIA Group |
2.71 - 4.74 |
1.38 - 2.15 |
||||||||||||||
Robust mean of RIA Group |
3.41 ( n = 7 ) |
1.54 ( n = 7 ) |
||||||||||||||
Robust SD of RIA Group |
0.799 |
0.165 |
||||||||||||||
CV of RIA Group |
23.4% |
10.7% |
||||||||||||||
Median of European RIA Labs |
3.08 ( n = 101 ) |
1.53 ( n = 101 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
2.74 - 3.55 |
1.41 - 1.72 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 7 |
4 |
9 |
3.80 |
0.27 |
7.6 |
1.0 |
1.1 |
32 |
1.80 |
0.19 |
11.8 |
1.5 |
1.4 |
49 |
RH02c | RH02 | 3 |
4 |
1 |
2.56 |
-0.97 |
-27.5 |
-3.4 |
-1.1 |
-115 |
1.23 |
-0.38 |
-23.6 |
-2.9 |
-0.9 |
-98 |
RH06 | RH06 | 7 |
4 |
9 |
3.72 |
0.19 |
5.4 |
0.7 |
0.9 |
22 |
1.66 |
0.05 |
3.1 |
0.4 |
0.9 |
13 |
RH07a | RH07 | 7 |
4 |
2 |
3.06 |
-0.47 |
-13.3 |
-1.7 |
-0.2 |
-56 |
1.31 |
-0.30 |
-18.6 |
-2.3 |
-0.6 |
-78 |
RH12 | RH12 | 3 |
4 |
2 |
3.03 |
-0.50 |
-14.2 |
-1.8 |
-0.3 |
-59 |
1.28 |
-0.33 |
-20.5 |
-2.6 |
-0.7 |
-85 |
RH15b | RH15b | 4 |
4 |
13 |
3.73 |
0.20 |
5.7 |
0.7 |
0.9 |
24 |
1.61 |
0.00 |
0.0 |
0.0 |
0.7 |
0 |
RH19 | RH19 | 7 |
4 |
2 |
3.14 |
-0.39 |
-11.0 |
-1.4 |
-0.1 |
-46 |
1.28 |
-0.33 |
-20.5 |
-2.6 |
-0.7 |
-85 |
RH20 | RH20 | 8 |
4 |
7 |
3.02 |
-0.51 |
-14.4 |
-1.8 |
-0.3 |
-60 |
1.51 |
-0.10 |
-6.2 |
-0.8 |
0.2 |
-26 |
CL005 | CL005 | 7 |
4 |
9 |
3.97 |
0.44 |
12.5 |
1.6 |
1.4 |
52 |
1.81 |
0.20 |
12.4 |
1.6 |
1.5 |
52 |
CL006a | CL006 | 4 |
4 |
7 |
3.05 |
-0.48 |
-13.6 |
-1.7 |
-0.3 |
-57 |
1.55 |
-0.06 |
-3.7 |
-0.5 |
0.4 |
-16 |
CL008 | CL008 | 7 |
4 |
2 |
3.24 |
-0.29 |
-8.2 |
-1.0 |
0.1 |
-34 |
1.27 |
-0.34 |
-21.1 |
-2.6 |
-0.7 |
-88 |
CL011 | CL011 | 0 |
4 |
13 |
3.71 |
0.18 |
5.1 |
0.6 |
0.9 |
21 |
1.61 |
0.00 |
0.0 |
0.0 |
0.7 |
0 |
CL013b | CL013b | 2 |
4 |
1 |
2.34 |
-1.19 |
-33.7 |
-4.2 |
-1.5 |
-141 |
1.19 |
-0.42 |
-26.1 |
-3.3 |
-1.1 |
-109 |
CL014b | CL014 | 7 |
4 |
1 |
2.51 |
-1.02 |
-28.9 |
-3.6 |
-1.2 |
-121 |
1.23 |
-0.38 |
-23.6 |
-2.9 |
-0.9 |
-98 |
CL015b | CL015b | 3 |
4 |
7 |
3.12 |
-0.41 |
-11.6 |
-1.5 |
-0.1 |
-48 |
1.48 |
-0.13 |
-8.1 |
-1.0 |
0.1 |
-34 |
Median of CLIA Group |
3.12 |
1.48 |
||||||||||||||
Range of CLIA Group |
2.34 - 3.97 |
1.19 - 1.81 |
||||||||||||||
Robust mean of CLIA Group |
3.20 ( n = 15 ) |
1.45 ( n = 15 ) |
||||||||||||||
Robust SD of CLIA Group |
0.566 |
0.242 |
||||||||||||||
CV of CLIA Group |
17.7% |
16.7% |
||||||||||||||
Median of European CLIA Labs |
3.60 ( n = 1030 ) |
1.62 ( n = 1030 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
2.77 - 3.89 |
1.27 - 1.73 |
||||||||||||||
Median of All Labs |
3.13 |
1.50 |
||||||||||||||
Range of All Labs |
2.34 - 4.74 |
1.19 - 2.15 |
||||||||||||||
Robust mean of All Labs |
3.25 ( n = 22 ) |
1.48 ( n = 22 ) |
||||||||||||||
Robust SD of All Labs |
0.583 |
0.224 |
||||||||||||||
CV of All Labs |
17.9% |
15.1%
|
||||||||||||||
Median of All European Labs ( Xa ) |
3.53 |
1.61 |
||||||||||||||
uXa |
0.020 |
0.008 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
2.76 - 3.89 |
1.28 - 1.73 |
||||||||||||||
Mean of All European Labs |
3.38 ( n = 1196 ) |
1.54 ( n = 1196 ) |
||||||||||||||
SD of All European Labs |
0.546 |
0.212 |
||||||||||||||
CV of All European Labs |
16.1% |
13.8% |
||||||||||||||
SD for proficiency assessment ( σp ) |
0.282 |
0.129 |
||||||||||||||
Adjusted SD for proficiency assessment ( σp ' ) |
- |
- |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH15b, RH19, RH20, CL005, CL006a, CL008, CL011, CL013b, CL014b, CL015b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL013b, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, CL015b, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
RH15b, CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 臺北信維郵局第 624 信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2017-10-05